During the past decade, University of Miami Don Suffer Clinical Research Building conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami Don Suffer Clinical Research Building" #1 sponsor was "University of Miami" with 12 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Shire" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami Don Suffer Clinical Research Building" #1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Biotics, Inc." with 1 trials as a collaborator, "CellHealth Institute" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Immuno Laboratories" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami Don Suffer Clinical Research Building" are "Diabetic Peripheral Neuropathic Pain" (3 trials), "Family Member" (3 trials), "Depression" (2 trials), "HIV" (2 trials) and "Hereditary Angioedema (HAE)" (2 trials). Many other conditions were trialed in "University of Miami Don Suffer Clinical Research Building" in a lesser frequency.

Most popular intervention types in "University of Miami Don Suffer Clinical Research Building" are "Drug" (16 trials), "Dietary Supplement" (6 trials), "Behavioral" (4 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "LY3556050" (3 trials), "Ocrelizumab" (2 trials), "ecallantide" (2 trials) and "Alteplase" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami Don Suffer Clinical Research Building" are 24 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Miami Don Suffer Clinical Research Building". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in University of Miami Don Suffer Clinical Research Building, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami Don Suffer Clinical Research Building, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

University of Miami Don Suffer Clinical Research Building has several departments that took part in Clinical trials: "UM Sylvester Comprehensive Cancer Center at Deerfield Beach" - 142 trials, "UM Sylvester Comprehensive Cancer Center at Plantation" - 77 trials, "UM Sylvester Comprehensive Cancer Center at Kendall" - 42 trials, "University of Miami, Diabetes Research Institute" - 36 trials, "UM Sylvester Comprehensive Cancer Center at Hollywood" - 15 trials, "UM Sylvester Comprehensive Cancer Center at Coral Springs" - 6 trials, "Batchelor Children's Research Institute - University of Miami" - 4 trials, "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center" - 2 trials